Oxidative stress in cancer biology and therapy pdf

Posted on Wednesday, March 17, 2021 11:47:02 PM Posted by AgnГЁs R. - 18.03.2021 and pdf, management pdf 0 Comments

oxidative stress in cancer biology and therapy pdf

File Name: oxidative stress in cancer biology and therapy .zip

Size: 2794Kb

Published: 18.03.2021

During the last 30 years it has become clearly evident that oxidative stress and free radical biology play key roles in carcinogenesis, cancer progression, cancer therapy, and normal tissue damage that limits treatment efficacy during cancer therapy.

The role of oxidative stress in activity of anticancer thiosemicarbazones

Metrics details. Reactive oxygen species ROS damage DNA, but the role of ROS in breast carcinoma may not be limited to the mutagenic activity that drives carcinoma initiation and progression.

Carcinoma cells in vitro and in vivo are frequently under persistent oxidative stress. In the present review, we outline potential causes of oxygen radical generation within carcinoma cells and explore the possible impact of oxidative stress on the clinical outcome of breast carcinoma.

Oxygen radicals are continuously generated within mammalian cells, this being a consequence of the use of oxygen in aerobic respiration. Superoxide is generated within the mitochondria and is sequentially reduced to hydrogen peroxide and hydroxyl radicals. These species damage DNA, producing the mutations that initiate tumours and sustain progression [ 1 ].

Epidemiological studies suggest that a diet that is rich in antioxidants may help to prevent the development of breast carcinoma; this evidence contributed to recent UK Government advice that individuals should consume at least five portions of fruit or vegetables each day.

The role of ROS in breast carcinoma may not be limited to early mutagenic events, however. Carcinoma cells are frequently under persistent oxidative stress. Human tumour cell lines in vitro produce ROS at a far greater rate than do non-transformed cell lines [ 2 ], and markers of constitutive oxidative stress have been detected in samples from in vivo breast carcinomas [ 3 , 4 ]. It appears unlikely that such a high level of oxidatively modified DNA is exclusively due to the mutagens that initiated the tumour.

Persistent oxidative stress within carcinoma cells may instead be responsible for the accumulation of 8-hydroxy-2'-deoxyguanosine. Oxygen radicals are not only generated in the mitochondria. The radicals are generated for cell killing and bactericidal activities. A panel of human tumour cell lines were shown to produce large quantities of hydrogen peroxide in vitro [ 2 ]. The hydrogen peroxide production was prevented by diphenyleneiodonium, which is an inhibitor of the flavoprotein component of the NADPH-oxidase.

Carcinoma cell oxidative stress can also be induced by thymidine phosphorylase, an enzyme that is overexpressed in the majority of breast carcinomas.

Thymidine phosphorylase catabolizes thymidine to thymine and 2-deoxy-D-ribosephosphate; the latter is a very powerful reducing sugar that rapidly glycates proteins, generating oxygen radicals within the carcinoma cell. Thymidine phosphorylase activity has been shown to induce carcinoma cell oxidative stress in vitro [ 6 ]. The frequent upregulation of thymidine phosphorylase in human breast tumours suggests that this may be an important cause of oxidative stress in breast cancer.

Oxidative stress within breast carcinoma may also be caused by a breast specific mechanism, namely the metabolism of oestrogenic hormones by lactoperoxidase. The above metabolic changes will elicit carcinoma cell oxidative stress both in vitro and in vivo.

We now consider further mechanisms by which tumour oxidative stress may arise. These, however, are dependent on the in vivo setting of the cancer. A breast tumour rapidly outgrows its blood supply, leading to glucose deprivation and hypoxia. Glucose deprivation rapidly induces cellular oxidative stress within the MCF-7 breast carcinoma cell line, although it does not cause oxidative stress in nontransformed cell lines [ 8 , 9 ].

This may be because glucose deprivation depletes intracellular pyruvate within the breast carcinoma cell, preventing the decomposition of endogenous oxygen radicals [ 8 ].

Breast carcinomas usually support their growth by stimulating blood vessel development angiogenesis. Blood flow within these new vessels is often chaotic, causing periods of hypoxia followed by reperfusion. Reperfusion after myocardial infarction or cerebral ischaemia is known to cause the generation of ROS. Oxygen radical production during reperfusion may therefore be a cause of oxidative stress within breast carcinomas.

Breast tumours are frequently infiltrated by large numbers of macrophages. These may contribute to carcinoma cell oxidative stress, as tumour-associated macrophages have been shown to deliver a sublethal oxidative stress to murine mammary tumour cells [ 10 ]. This may be due to oxygen radical production by the macrophages. Some anticancer therapies may add to the oxidative stress within breast carcinomas.

The chemotherapeutic agents doxorubicin, mitomycin C, etoposide and cisplatin are superoxide generating agents [ 12 ]. Radiotherapy and photodynamic therapy generate oxygen radicals within the carcinoma cell. The antioestrogen tamoxifen, increasingly used alongside other breast cancer therapies, has also been shown to induce oxidative stress within carcinoma cells in vitro [ 13 ].

As previously noted, oxygen radicals are powerful DNA damaging agents. ROS cause strand breaks, alterations in guanine and thymine bases, and sister chromatid exchanges [ 1 ]. This may inactivate additional tumour suppressor genes within tumour cells, or further increase expression of proto-oncogenes. Genetic instability due to persistent carcinoma cell oxidative stress will therefore increase the malignant potential of the tumour [ 2 ].

Sublethal oxidative stress promotes cell proliferation in vitro , with both superoxide and hydrogen peroxide stimulating growth [ 14 ]. Proliferation in response to hydrogen peroxide may be due to the activation of mitogen-activated protein kinases MAPKs.

Hyperphosphorylation of c-Jun by oxidative stress activates activator protein-1 in MCF-7 breast carcinoma cells, a response that stimulates proliferation [ 16 ], and multidrug-resistant human breast carcinoma cells rapidly activate extracellular signal related protein kinase-2 when stressed by glucose deprivation [ 9 ]. Severe oxidative stress leads to apoptosis. Conversely, persistent oxidative stress at sublethal levels may cause resistance to apoptosis.

The induction of programmed cell death by ROS is dependent on p53 in both mouse and human cell lines [ 18 ]. Constitutive oxidative stress within breast carcinoma cells may therefore accelerate the selection of p53 knockout tumour cell clones, which have an apoptosis resistant phenotype.

Persistent oxidative stress may also cause adaptive responses within the tumour cell that confer resistance to apoptosis.

The antioxidant thiols thioredoxin and metallothionein are rapidly upregulated in response to oxidative stress [ 12 , 19 ], and the antioxidants malondialdehyde, superoxide dismutase, glutathione peroxidase and catalase show increased expression or activity in breast tumour tissue as compared with normal controls [ 4 ].

An upregulation of anti-ROS defences in cancer cells may explain why tumour cell lines in vitro are extremely resistant to cytolysis by hydrogen peroxide [ 20 ]. In addition, antiapoptotic Akt protein kinase B is activated by hydrogen peroxide [ 21 ]. An antiapoptotic response to chronic oxidative stress may have severe implications for anticancer therapy. As outlined above, radiotherapy, photodynamic therapy and many chemotherapies generate oxygen radicals.

Their antitumour activity is to a degree dependent on the induction of tumour cell apoptosis in response to oxidative stress and oxygen radical induced DNA damage [ 12 ]. Persistent oxidative stress within carcinoma cells may therefore cause resistance to therapy. Oxygen radicals might also increase drug resistance by increasing carcinoma cell expression of P-glycoprotein, the multidrug-resistance efflux pump [ 22 ].

Oxygen radicals increase tumour cell production of the angiogenic factors IL-8 and vascular endothelial growth factor VEGF [ 6 ]. Tumour cell oxidative stress also promotes secretion of the matrix metalloproteinase-1 MMP-1 , a collagenase that aids vessel growth within the tumour microenvironment [ 6 ]. Oxidative stress can therefore cause angiogenesis within breast carcinoma.

Hypoxia and oxidative stress may be found together within the tumour, and VEGF production within oxidatively stressed breast carcinomas may be augmented by synergy between oxygen radicals and tumour hypoxia. Levels of the hypoxia inducible factor-1 HIF-1 may be increased by oxygen radicals [ 23 , 24 ], implying that oxidatively stressed carcinoma cells might show increased HIF-1 induction during hypoxia and therefore produce more VEGF Fig.

Oxygen radicals and oxygen insufficiency hypoxia co-operatively promote tumour angiogenesis. Breast carcinomas frequently outgrow their blood supply, leading to oxygen insufficiency hypoxia within the tumour. Hypoxia causes necrosis, and DNA is subsequently degraded to its constituent bases. Any thymidine released is catabolized by thymidine phosphorylase, an enzyme that is frequently overexpressed within breast carcinomas.

Thymidine phosphorylase activity causes oxygen radical production, as described by Brown et al [ 6 ]. Reoxygenation of the tumour after hypoxia will drive additional oxygen radical formation.

Breast tumours are also oxidatively stressed by nonhypoxic mechanisms, such as glucose deprivation, metabolic alterations and macrophage infiltration.

HIF-1 levels may also be increased by oxygen radicals. Oxidative stress may also increase the blood supply to breast carcinoma by triggering vasodilatation. Hydrogen peroxide induces inducible nitric oxide synthase NOS in cytokine stimulated rat pleural mesothelial cells [ 25 ], raising the possibility that oxidatively stressed breast tumour cells might show increased expression of inducible NOS. The nitric oxide produced would activate cGMP within nearby smooth muscle cells, leading to vasodilatation.

Vasodilatation could also be triggered by carbon monoxide, because oxidative stress powerfully induces heme oxygenase-1 [ 6 ], which degrades heme to biliverdin and carbon monoxide.

Carbon monoxide, like nitric oxide, activates cGMP. Blood vessel growth within the breast tumour microenvironment increases the risk of blood-borne metastasis. Angiogenesis may also promote lymphatic dissemination, a common occurrence in breast carcinoma, by elevating tumour interstitial pressure. These are not the only mechanisms by which oxidative stress can aid tumour spread, however.

Oxygen radicals may also augment tumour cell migration, increasing the risk of invasion and metastasis. The p38 MAPK is activated by oxidative stress [ 15 ], and the phosphorylation of heat shock protein by p38 MAPK has been shown to induce changes in actin dynamics [ 26 ]. Phosphorylated heat shock protein promotes the migration of MDA-MB breast cancer cells on laminin-5 in vitro [ 27 ].

ROS have been shown to mediate the role of Rac1 in actin cytoskeleton reorganization [ 28 ]. Oxidative stress within breast tumours may also facilitate invasion and metastasis by activating MMPs and inhibiting antiproteases. MMP-2 is a gelatinase that is believed to play a major role in breast cancer invasion and metastasis. High levels of MMP-2 correlate with poor prognosis in breast cancer patients [ 29 ] and active MMP-2 is detected more frequently in malignant than in benign breast tumours.

This facilitates the activity of various proteases, increasing invasion and the likelihood of metastasis. For example, plasminogen activator is believed to play a role in metastasis [ 2 ].

Murine mammary carcinoma cells that are exposed to sublethal oxidative stress exhibit decreased attachment to immobilized laminin and fibronectin [ 10 ]. Reduced tumour cell adhesion to basement membrane components increases the probability that the cells will detach and enter the blood vessels or lymphatic system. In addition, treatment of these cells with hydrogen peroxide, before intravenous injection into mice, enhanced lung metastasis formation. This implies that oxidative stress may aid the seeding of metastatic tumour cells [ 10 ].

Finally, ROS within the tumour microenvironment may promote metastasis by increasing vascular permeability, either by direct damage to endothelial cells or by the upregulation of inducible NOS and heme oxygenase-1 previously proposed. Carcinoma cells synthesize ROS at an elevated rate in vitro , and many tumours in vivo appear to be under persistent oxidative stress.

The present review outlines potential causes of carcinoma cell oxidative stress in vitro and in vivo , and summarizes mechanisms by which oxygen radicals may affect the outcome of breast cancer. Future experiments will reveal the extent to which oxidative stress influences the prognosis of breast carcinoma.

If oxygen radicals do lead to a poorer prognosis, then antioxidants may be of therapeutic value. This is an exciting possibility, because antioxidants are drugs of low toxicity.

Role of Redox Homeostasis in Cancer Biology and Anticancer Therapy

Alexandr V. Bazhin, Pavel P. Our understanding of reactive oxygen species ROS —a group of highly reactive chemicals containing oxygen—has changed in the last few years from ROS as just harmful substances to crucial intra- and extracellular messengers as well as important regulators controlling a wide spectrum of signaling pathways. Nevertheless, there are still many uninvestigated points and open questions regarding ROS, especially in pathophysiology. Delicately controlled ROS homeostasis is critical for maintaining normal cell functions and any disruption in the oxidation-antioxidation balance leads to oxidative stress associated with a wide spectrum of human disorders such as chronic inflammation, age-related diseases, and cancers. In health, the intracellular ROS level is tightly controlled by various antioxidants.

Hot Keywords non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence. Correspondence Address: Dr. E-mail: ying. E-mail: flc6 georgetown. Hepatocellular carcinoma HCC is the second leading cause of cancer-related deaths worldwide.

Oxidative stress and hepatocarcinogenesis

Ankita Bansal, M. Celeste Simon; Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 2 July ; 7 : —

Search this site. Alexander the Great PDF. American Journal of Mathematics, , Vol.

Metrics details. Reactive oxygen species ROS damage DNA, but the role of ROS in breast carcinoma may not be limited to the mutagenic activity that drives carcinoma initiation and progression.

Rekindling vitamin C cancer therapy: oral vs intravenous administration

January 24, , by Lewis Cantley and Jihye Yun. Lewis Cantley received his Ph. Jihye Yun received her Ph. The discovery and isolation of vitamin C was one of the most important advances in improving human nutrition. Scurvy, a severe vitamin C deficiency disease characterized by weakness, lethargy, easy bruising and bleeding, was particularly problematic for sailors on long voyages during the 16th century, where access to fresh fruits and vegetables was limited. In fact, scurvy was the leading cause of naval deaths between the 16th and 18th centuries, killing more sailors than all battles, storms and other diseases combined. However, it took scientists nearly two more centuries to identify the nature of the curative substance contained in citrus fruits, now commonly known as vitamin C.

It seems that you're in Germany.